Regulation of autoimmunity by proinflammatory cytokines

Vassalli, 1992, The pathophysiology of tumor necrosis factors, Annu Rev Immunol, 10, 411, 10.1146/annurev.iy.10.040192.002211 Cope, 1997, The role of TNFα and related cytokines in the development and function of the autoreactive T-cell repertoire, Res Immunol, 148, 307, 10.1016/S0923-2494(97)87239-2 Dhein, 1995, Autocrine T-cell suicide mediated by APO-1/CD95, Nature, 373, 438, 10.1038/373438a0 Brunner, 1995, Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas, Nature, 373, 441, 10.1038/373441a0 Ju, 1995, Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation, Nature, 373, 444, 10.1038/373444a0 Tartaglia, 1993, A novel domain within the 55kd TNF receptor signals cell death, Cell, 74, 845, 10.1016/0092-8674(93)90464-2 Zheng, 1995, Induction of apoptosis in mature T cells by tumour necrosis factor, Nature, 377, 348, 10.1038/377348a0 Speiser, 1996, Tumour necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo, Eur J Immunol, 26, 3055, 10.1002/eji.1830261235 Sytwu, 1996, The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice, Immunity, 5, 17, 10.1016/S1074-7613(00)80306-4 Sarin, 1995, Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts, J Immunol, 155, 3716, 10.4049/jimmunol.155.8.3716 Cohen, 1991, Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease, Annu Rev Immunol, 9, 243, 10.1146/annurev.iy.09.040191.001331 Pasparakis, 1996, Immune and inflammatory responses in TNFα-deficient mice: a central requirement of TNFα in the formation of primary B cell follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response, J Exp Med, 184, 1397, 10.1084/jem.184.4.1397 Pasparakis, 1997, Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor, Proc Natl Acad Sci USA, 94, 6319, 10.1073/pnas.94.12.6319 Marino, 1997, Characterization of tumor necrosis factor-deficient mice, Proc Natl Acad Sci USA, 94, 8093, 10.1073/pnas.94.15.8093 Salmon, 1997, Inhibition of T cell apoptosis in the rheumatoid synovium, J Clin Invest, 99, 439, 10.1172/JCI119178 Vella, 1995, Lipopolysaccharide interferes with the induction of peripheral T cell death, Immunity, 2, 261, 10.1016/1074-7613(95)90050-0 Pape, 1997, Inflammatory cytokines enhance the in vivo clonal expansion and differentiation of antigen-activated CD4+ T cells, J Immunol, 159, 591, 10.4049/jimmunol.159.2.591 Liu, 1996, Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death, Cell, 87, 565, 10.1016/S0092-8674(00)81375-6 Beg, 1996, An essential role for NF-κB in preventing TNF-α-induced cell death, Science, 274, 782, 10.1126/science.274.5288.782 Wang, 1996, TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB, Science, 274, 784, 10.1126/science.274.5288.784 Van Antwerp, 1996, Suppression of TNF-α-induced apoptosis by NF-κB, Science, 274, 787, 10.1126/science.274.5288.787 Tartaglia, 1992, Two TNF receptors, Immunol Today, 13, 151, 10.1016/0167-5699(92)90116-O Sallusto, 1994, Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α, J Exp Med, 179, 1109, 10.1084/jem.179.4.1109 Jacob, 1988, Tumour necrosis factor-α in murine autoimmune ‘lupus’ nephritis, Nature, 331, 356, 10.1038/331356a0 Ishida, 1994, Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice, J Exp Med, 179, 305, 10.1084/jem.179.1.305 Gordon, 1989, Chronic therapy with recombinant tumor necrosis factor-α in autoimmune NZB/W F1 mice, Clin Immunol Immunopathol, 52, 421, 10.1016/0090-1229(89)90157-8 Zhou, 1996, Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor 1, J Immunol, 156, 2661, 10.4049/jimmunol.156.8.2661 Gordon, 1990, Effects of recombinant murine tumor necrosis factor-α on immune function, J Immunol, 144, 1753, 10.4049/jimmunol.144.5.1753 Cope, 1994, Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis, J Clin Invest, 94, 749, 10.1172/JCI117394 Lorenz, 1996, In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects, J Immunol, 156, 1646, 10.4049/jimmunol.156.4.1646 Lai, 1995, Role of tumor necrosis factor-α in the regulation of activated synovial T cell growth: downregulation of synovial T cells in rheumatoid arthritis, Eur J Immunol, 25, 3243, 10.1002/eji.1830251207 Cope, 1997, Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling, J Exp Med, 185, 1573, 10.1084/jem.185.9.1573 Grewal, 1996, Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells, J Exp Med, 184, 1963, 10.1084/jem.184.5.1963 McSorley, 1997, Immunological tolerance to a pancreatic antigen as a result of local expression of TNFalpha by islet beta cells, Immunity, 7, 401, 10.1016/S1074-7613(00)80361-1 DiCosmo, 1994, Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice, Int Immunol, 6, 1829, 10.1093/intimm/6.12.1829 Rincon, 1997, Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells, J Exp Med, 185, 461, 10.1084/jem.185.3.461 Maurice, 1997, Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis, J Immunol, 159, 2973, 10.4049/jimmunol.159.6.2973 Liu, 1998, TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination, Nat Med, 4, 78, 10.1038/nm0198-078 Probert, 1998, TNF and receptors in CNS function: friend or foe [abstract], J Interferon Cytokine Res, 18, A83 Probert, 1998, TNF and receptors in CNS function: friend or foe [abstract], J Interferon Cytokine Res, 18, A92 Marino, 1998, Anti-inflammatory activities of TNF [abstract], J Interferon Cytokine Res, 18, A81 van Oosten, 1996, Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2, Neurology, 47, 1531, 10.1212/WNL.47.6.1531 Berger, 1997, Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes, Eur J Immunol, 27, 2994, 10.1002/eji.1830271136 Feldmann, 1996, Role of cytokines in rheumatoid arthritis, Annu Rev Immunol, 14, 397, 10.1146/annurev.immunol.14.1.397 Bohm, 1997, Regulatory mechanisms that modulate signalling by G-protein-coupled receptors, Biochem J, 322, 1, 10.1042/bj3220001 Yeh, 1997, Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice, Immunity, 7, 715, 10.1016/S1074-7613(00)80391-X Kelliher, 1998, The death domain kinase RIP mediates the TNF-induced NF-kappaB signal, Immunity, 8, 297, 10.1016/S1074-7613(00)80535-X Cope, 1995, Soluble TNF receptor production by activated T lymphocytes: differential effects of acute and chronic exposure to TNF, Immunology, 84, 21 Petricoin, 1997, Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling, Nature, 390, 629, 10.1038/37648 Bacon, 1996, RANTES induces tyrosine kinase activity of stably complexed p125FAK and ZAP-70 in human T cells, J Exp Med, 184, 873, 10.1084/jem.184.3.873 Jacob, 1990, Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1, Proc Natl Acad Sci USA, 87, 968, 10.1073/pnas.87.3.968 Liossis, 1998, Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain, J Clin Invest, 101, 1448, 10.1172/JCI1457 Hotamisligil, 1994, Tumor necrosis factor alpha inhibits signaling from the insulin receptor, Proc Natl Acad Sci USA, 91, 4854, 10.1073/pnas.91.11.4854 Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science, 271, 665, 10.1126/science.271.5249.665 Satoh, 1989, Recombinant human tumor necrosis factor α suppresses autoimmune diabetes in non-obese diabetic mice, J Clin Invest, 84, 1345, 10.1172/JCI114304 Jacob, 1992, Monoclonal anti-tumor necrosis factor antibody renders non-obese diabetic mice hypersensitive to irradiation and enhances insulitis development, Int Immunol, 4, 611, 10.1093/intimm/4.5.611 Satoh, 1990, Inhibition of type I diabetes in BB rats with recombinant human tumor necrosis factor-α, J Immunol, 145, 1395, 10.4049/jimmunol.145.5.1395 Higuchi, 1992, Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes, J Exp Med, 176, 1719, 10.1084/jem.176.6.1719 Picarella, 1993, Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice, J Immunol, 150, 4136, 10.4049/jimmunol.150.9.4136